Acadian Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,210
Closed -$42K 1656
2021
Q4
$42K Buy
+3,210
New +$40.4K ﹤0.01% 1510
2019
Q4
Sell
-14,594
Closed -$53K 1925
2019
Q3
$53K Hold
14,594
﹤0.01% 1601
2019
Q2
$61K Buy
+14,594
New +$58.4K ﹤0.01% 1443
2018
Q2
Sell
-36,188
Closed -$255K 1717
2018
Q1
$255K Sell
36,188
-260,837
-88% -$1.93M ﹤0.01% 1007
2017
Q4
$2.29M Buy
297,025
+76,768
+35% +$640K 0.01% 533
2017
Q3
$1.84M Buy
+220,257
New +$1.37M 0.01% 583
2016
Q1
Sell
-53,804
Closed -$1.07M 1379
2015
Q4
$1.07M Buy
53,804
+40,131
+294% +$991K 0.01% 680
2015
Q3
$331K Buy
+13,673
New +$355K ﹤0.01% 832

Other funds holding CLMT

Acadian Asset Management's CLMT Position: Q1 2022 in Review

Acadian Asset Management sold out of Calumet Specialty Products (CLMT) in Q1 2022, closing a stake of 3,210 shares — an estimated $42K sold.

Acadian Asset Management first reported a position in CLMT in Q3 2015 and held it in 8 quarters. The position peaked at $2.29M in Q4 2017. 61 funds tracked by Wall St. Rank hold CLMT as of Q1 2022.

  • Acadian Asset Management reported no remaining Calumet Specialty Products position as of Q1 2022 after selling out during the quarter.
  • Acadian Asset Management sold 3,210 Calumet Specialty Products shares in Q1 2022, an estimated $42K.
  • Acadian Asset Management first reported a position in Calumet Specialty Products in Q3 2015 and held it in 8 quarters.
  • Acadian Asset Management's Calumet Specialty Products position peaked at $2.29M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2022.

Based on Acadian Asset Management's 13F filing for Q1 2022, filed 12 May 2022.